Fufeng Group Limited — Capital/Financing Update 2013

Apr 19, 2013

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [74 x 57] intentionally omitted <==

Fufeng Group Limited 阜豐集團有限公司

(incorporated in the Cayman Islands with limited liability)

(Stock code: 546)

ANNOUNCEMENT IN RELATION TO ISSUE OF DOMESTIC MEDIUM TERM NOTES IN THE PRC BY NEIMENGGU FUFENG BIOTECHNOLOGIES CO., LTD. A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY

This announcement is made by Fufeng Group Limited pursuant to Rule 13.09 of the Rules Governing the Listing of Securities on the Stock Exchange of Hong Kong Limited (the “Listing Rules”) and Inside Information Provisions under Part XIVA of the Securities and Futures Ordinance (Chapter 571, Laws of Hong Kong) (the “SFO”).

Reference is made to the announcement of the Company dated 9 April 2013 regarding the issue of domestic Medium Term Notes in the PRC by Neimenggu Fufeng Biotechnologies Co., Ltd. (“Neimenggu Fufeng”), a wholly-owned subsidiary of the Company (the “Announcement”). Unless otherwise defined, all capitalized terms shall bear the same meanings as in the Announcement.

The Board is pleased to announce that the Issuer has completed the issue of the first tranche of Medium Term Notes on 18 April 2013. The aggregate principal amount of the first tranche of Medium Term Notes is RMB600 million. The Medium Term Notes has a term of 3 years at a fixed coupon rate 5.11% per annum. Interests will accrue from 18 April 2013. Both the par value and the issuing price of the Medium Term Notes are RMB100 per unit. China Merchants Bank Co., Ltd acted as the Lead Manager.

The net proceeds from the first tranche of the Medium Term Notes will be used for repayment of bank loans and as general working capital of the Issuer and its subsidiaries.

In accordance with the relevant laws and regulations in the PRC, relevant documents in relation to the Issuer and the Medium Term Notes will be published on the websites of China Bond (http://www.chinabond.com.cn) and China Foreign Exchange Trade System (www.chinamoney.com.cn).

– 1 –

DEFINITIONS

In this announcement, the following expressions shall have the following meanings unless the context otherwise requires:

“Board”	the board of directors of the Company
“Company”	Fufeng Group Limited, a limited liability company
	incorporated in Cayman Islands, the shares of which are
	listed on the main board of the Stock Exchange
“Group”	the Company and its subsidiaries
“Hong Kong”	Hong Kong Special Administrative Region of the People’s
	Republic of China
“Issuer”	Neimenggu Fufeng Biotechnologies Co., Ltd., a limited
	liability company established in the PRC and a wholly-
	owned subsidiary of the Company
“Medium Term Notes”	the domestic medium term notes of an aggregate registered
	amount subject to a cap of RMB1.2 billion to be issued by
	the Issuer in the PRC
“PRC”	the People’s Republic of China and, for the purposes of this
	announcement, excludes Hong Kong, the Macau Special
	Administrative Region of the People’s Republic of China
	and Taiwan
“RMB”	Renminbi, the lawful currency of the PRC
“Shareholder(s)”	shareholder(s) of the Company
“Stock Exchange”	The Stock Exchange of Hong Kong Limited
	By Order of the Board
	Fufeng Group Limited
	Li Xuechun
	Chairman

Hong Kong, 19 April 2013

As at the date of this announcement, the executive directors of the Company are Mr. Li Xuechun, Mr. Wang Longxiang, Mr. Feng Zhenquan, Mr. Xu Guohua, Mr. Li Deheng, Mr. Chen Yuan and Mr. Li Guangyu and the independent non-executive directors of the Company are Mr. Choi Tze Kit, Sammy, Mr. Chen Ning, Mr. Liang Wenjun and Ms. Zheng Yu.

– 2 –